marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-03-2023
Paratek Pharmaceuticals Financial Ratios 2011-2024 | PRTK
Annual Financial Ratios Paratek Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.3 | -3.3 | -3.1 | -0.9 | -1.9 | -4.7 | -2.6 | -3.4 | -3.5 | -0.6 | -2.0 | -6.8 |
P/S |
0.5 | 32.7 | 6.3 | 6.7 | 12.2 | 33.3 | 9951.9 | - | 14.4 | 8.8 | 2.2 | 1.3 |
EPS |
-1.2 | -1.2 | -2.2 | -3.9 | -3.6 | -3.3 | -5.5 | -4.3 | -7.8 | -185.1 | -0.7 | -0.3 |
EV (Enterprise Value) |
390 M | 427 M | 469 M | 299 M | 415 M | 466 M | 300 M | 155 M | -18.7 M | 16 M | -12.3 M | 19 M |
EBITDA per Share |
-0.84 | -0.84 | -1.65 | -3.57 | -3.34 | -3.1 | -5.31 | -4.24 | -2.5 | -15.5 | -8.18 | -3.02 |
EV/EBITDA |
-10.4 | -5.9 | -2.3 | -3.7 | -5.3 | -2.6 | -1.8 | 5.3 | -0.2 | 1.3 | -4.6 | |
PEG |
0.07 | 0.13 | -0.12 | 0.08 | 0.25 | -0.12 | 0.09 | -0.08 | -0.06 | 0.01 | 0.01 | -0.12 |
P/B |
-0.5 | -1.5 | -2.9 | -2.8 | 4.4 | 5.1 | 4.0 | 2.4 | 0.7 | 0.2 | 0.3 | 0.4 |
P/CF |
-1.2 | -4.1 | -2.8 | -0.8 | -2.6 | -5.3 | -3.0 | -4.3 | -3.4 | -1.0 | -1.6 | -4.6 |
ROE % |
37.16 | 46.24 | 94.41 | 324.84 | -236.15 | -107.99 | -155.93 | -69.99 | -18.73 | -38.26 | -12.60 | -5.90 |
ROA % |
-36.84 | -32.13 | -54.59 | -51.29 | -37.43 | -54.41 | -82.25 | -48.56 | -16.22 | -37.26 | -12.25 | -5.61 |
ROCE % |
27.02 | 32.19 | -49.38 | -50.97 | -36.83 | -57.46 | -95.24 | -56.41 | -6.14 | -34.02 | -12.43 | -5.72 |
Current Ratio |
0.5 | 0.6 | 6.9 | 10.1 | 14.4 | 9.6 | 6.5 | 6.9 | 27.1 | 38.2 | 35.7 | 19.7 |
DSO |
118.5 | 1256.7 | 122.4 | 211.4 | 5.3 | 170.4 | 4065.3 | - | 372.7 | 610.7 | 8.6 | - |
DIO |
218.3 | 216.7 | 614.1 | 1213.1 | - | - | - | - | - | - | - | - |
DPO |
84.7 | 61.1 | 76.5 | 431.2 | - | - | - | - | - | - | - | - |
Operating Cycle |
336.9 | 1473.4 | 736.5 | 1424.5 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
252.2 | 1412.4 | 660.0 | 993.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Paratek Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -0.35 | - | -0.38 | -0.33 | -0.35 | -0.64 | -0.37 | 0.2 | -0.39 | -0.54 | -0.46 | -0.53 | -0.66 | -0.81 | -1 | -1.02 | -1.1 | -0.71 | -1.01 | -0.94 | -0.91 | -0.78 | -0.77 | -0.66 | -1.14 | -1.16 | -1.04 | -1.69 | -1.78 | -1.2 | -1.33 | -0.96 | -0.74 | -1.16 | -29.48 | -42.23 | -20.93 | -0.29 | -0.25 | -0.36 | -0.56 | -0.35 | 0.26 | -0.3 | -0.37 | 0.39 | -0.37 | -0.17 | -0.14 |
EBITDA per Share |
- | -0.28 | - | -0.29 | -0.25 | -0.26 | -0.53 | -0.27 | 0.3 | -0.3 | -0.38 | -0.34 | -0.42 | -0.56 | -0.58 | -0.92 | -0.96 | -1.05 | -0.62 | -0.95 | -0.87 | -0.87 | -0.75 | -0.7 | -0.58 | -1.09 | -1.11 | -0.98 | -1.63 | -1.73 | -1.16 | -1.3 | -0.93 | -0.72 | -0.13 | -22.8 | -26.3 | -13.7 | -0.29 | -0.25 | -0.35 | -0.56 | -0.35 | 0.27 | -0.29 | -0.36 | 0.39 | -0.35 | -0.15 | -0.13 |
ROE % |
43.02 | 47.58 | 37.13 | 62.37 | 67.14 | 45.55 | 48.21 | 47.42 | 50.48 | 82.82 | 94.41 | 138.97 | 200.84 | 262.03 | 324.84 | 207.92 | 58.23 | -88.01 | -236.15 | -214.79 | -173.22 | -132.77 | -107.99 | -118.40 | -125.55 | -145.80 | -155.93 | -139.83 | -129.96 | -103.17 | -69.99 | -60.82 | -41.08 | -27.96 | -18.73 | -2.21 | -5.37 | -12.34 | -25.70 | -24.74 | -13.09 | -9.13 | 0.08 | 2.33 | -10.35 | -8.38 | -5.90 | -7.59 | -3.42 | -2.95 |
ROA % |
-49.88 | -50.42 | -34.32 | -51.86 | -38.05 | -32.64 | -33.63 | -30.23 | -32.04 | -50.49 | -54.59 | -51.35 | -52.54 | -52.73 | -51.29 | -47.99 | -45.69 | -42.37 | -37.43 | -43.21 | -45.55 | -46.75 | -54.41 | -60.53 | -64.91 | -76.11 | -82.25 | -77.22 | -75.86 | -64.31 | -48.56 | -44.21 | -31.10 | -22.40 | -16.22 | -436.84 | -440.29 | -447.33 | -460.48 | -36.43 | -25.09 | -21.23 | -12.25 | 2.09 | -10.08 | -8.09 | -5.61 | -7.22 | -3.25 | -2.80 |
ROCE % |
32.88 | 37.03 | 28.52 | 49.86 | 53.00 | 30.00 | 32.17 | 27.97 | 30.50 | 62.73 | 73.84 | 115.16 | 172.74 | 230.67 | 291.65 | 191.07 | 55.66 | -78.59 | -218.77 | -201.96 | -164.33 | -126.23 | -102.55 | -113.41 | -121.09 | -142.46 | -152.93 | -136.89 | -127.69 | -101.62 | -69.19 | -51.08 | -31.23 | -17.71 | -8.19 | -1.36 | -4.66 | -12.01 | -25.63 | -24.69 | -13.02 | -9.03 | 0.18 | 2.51 | -10.18 | -8.21 | -5.72 | -7.55 | -3.38 | -2.90 |
Current Ratio |
0.4 | 0.4 | 0.5 | 0.5 | - | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.9 | 0.9 | 0.9 | 0.9 | 1.2 | 1.2 | 1.2 | 1.2 | 2.0 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.1 | 3.3 | 3.3 | 3.3 | 3.3 | 7.5 | 7.5 | 7.5 | 7.5 | 0.0 | - | - | - | 36.8 | 29.1 | 31.4 | 37.2 | 20.3 | 20.3 | 20.3 | 20.3 |
DSO |
90.3 | 162.9 | - | 44.4 | 38.1 | 99.4 | 73.6 | 144.7 | 56.7 | 77.0 | 67.7 | 79.3 | 116.2 | 117.2 | 86.2 | 196.6 | 378.2 | 243.1 | 0.2 | 74.8 | 93.5 | 23186.6 | 90.7 | 38332.6 | 61.2 | 12777.5 | 361.9 | - | - | - | - | - | - | - | 101.2 | 2223.1 | 1376.2 | 4445.6 | 63.0 | - | - | -1.3 | -5.7 | - | - | - | 1.0 | - | - | - |
DIO |
265.3 | 223.3 | - | 216.5 | 119.1 | 310.2 | - | 178.5 | 103.4 | 477.0 | - | 658.5 | 594.0 | 810.6 | - | 1102.9 | 1863.5 | 2697.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
86.4 | 77.6 | - | 84.6 | 43.9 | 131.8 | - | 80.6 | 31.0 | 97.2 | - | 82.0 | 74.0 | 183.9 | - | 392.1 | 662.4 | 1374.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
355.7 | 386.2 | - | 260.9 | 157.2 | 409.6 | 73.6 | 323.1 | 160.2 | 554.0 | 67.7 | 737.8 | 710.2 | 927.8 | 86.2 | 1299.5 | 2241.6 | 2940.1 | 0.2 | 74.8 | 93.5 | 23186.6 | 90.7 | 38332.6 | 61.2 | 12777.5 | 361.9 | - | - | - | - | - | - | - | 101.2 | 2223.1 | 1376.2 | 4445.6 | 63.0 | - | - | -1.3 | -5.7 | - | - | - | 1.0 | - | - | - |
Cash Conversion Cycle |
269.3 | 308.6 | - | 176.3 | 113.2 | 277.8 | 73.6 | 242.5 | 129.2 | 456.9 | 67.7 | 655.8 | 636.2 | 743.9 | 86.2 | 907.4 | 1579.2 | 1565.6 | 0.2 | 74.8 | 93.5 | 23186.6 | 90.7 | 38332.6 | 61.2 | 12777.5 | 361.9 | - | - | - | - | - | - | - | 101.2 | 2223.1 | 1376.2 | 4445.6 | 63.0 | - | - | -1.3 | -5.7 | - | - | - | 1.0 | - | - | - |
All numbers in USD currency